MDM2 and esophageal squamous cell carcinoma: In conclusion, the results of this study suggest that MDM2 and p16 might have potential as predictive markers for chemoradioresistance in cStageIII ESCC and also that Ki-67 may also have a role as a putative prognostic marker following dCRT in cStageIII ESCC.